The class of chemicals identified as fizzy-related cell cycle modulators encompasses a range of compounds primarily known for their roles in cancer therapy. These chemicals are not direct activators of fizzy-related proteins but influence the cell cycle and mitosis, thereby having an indirect effect on the regulation of these proteins. The primary mechanism through which these modulators exert their influence involves the disruption of key processes essential for cell division, such as DNA replication, microtubule dynamics, and DNA repair. In the first paragraph of the description, I would delve into the specific mechanisms of action of these modulators.
Compounds like Paclitaxel and Vinblastine affect microtubule dynamics, crucial for the formation of the mitotic spindle, indirectly impacting the regulation of the cell cycle by fizzy-related proteins. Alkylating agents like Cyclophosphamide and DNA intercalating agents like Doxorubicin cause DNA damage, triggering a cascade of cellular responses that can influence cell cycle progression. Additionally, nucleoside analogs such as Gemcitabine and pyrimidine analogs like 5-Fluorouracil disrupt DNA synthesis, a critical phase in the cell cycle.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, affecting DNA synthesis and cell cycle. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and blocks progression of mitosis, indirectly affecting cell cycle regulators. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubule formation, impacting mitotic spindle function and cell cycle progression. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Alkylating agent that causes DNA damage, indirectly influencing cell cycle progression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Intercalates DNA and inhibits topoisomerase II, affecting DNA replication and cell cycle. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, leading to DNA damage and influencing cell cycle regulators. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
A nucleoside analog that interferes with DNA synthesis, indirectly affecting cell cycle progression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A pyrimidine analog that inhibits thymidylate synthase, affecting DNA synthesis and cell cycle. | ||||||
(+)-Irinotecan | 97682-44-5 | sc-269253 | 10 mg | $62.00 | 1 | |
Inhibits topoisomerase I, leading to DNA damage and affecting cell cycle regulators. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Forms DNA adducts, leading to DNA damage and influencing cell cycle progression. | ||||||